Esomeprazole Magnesium
Product Images NDC 68071-2922

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68071-2922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2922 6)

Label for Esomeprazole Magnesium 20 mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The label indicates a #60 count of oblong dark blue opaque hard gelatin capsules with "ESOM" printed on the cap and "20" on the body. Manufactured by Akrem Laboratories Ltd., India. Includes NDC 68071-2922-6 and Rx only status. Storage instructions specify controlled temperature 68-77°F and a warning to keep out of reach of children.*

FDA Label Image

Esomeprazole-fig2 (Esomeprazole Fig2)

A line graph showing percent maintained versus months for Esomeprazole Magnesium at 10 mg, 20 mg, 40 mg doses, and placebo. The graph tracks patient data over six months with scheduled visits marked, illustrating higher maintenance percentages for higher doses and lower for placebo.*

FDA Label Image

Esomeprazole-fig3 (Esomeprazole Fig3)

A line graph displaying the percent maintained over a 6-month period for Esomeprazole Magnesium at doses of 40 mg, 20 mg, and 10 mg compared to placebo. The y-axis represents percent maintained, and the x-axis represents months with scheduled visits marked. The graph shows higher maintenance rates with increasing doses of Esomeprazole compared to placebo, which declines over time.*

FDA Label Image

Esomeprazole-fig4 (Esomeprazole Fig4)

A line graph showing percent of patients symptom-free over a 28-day diary period. The graph compares three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The percent symptom-free generally increases over time, with Esomeprazole 40 mg and 20 mg groups showing higher percentages than placebo throughout the study.*

FDA Label Image

Esomeprazole-fig5 (Esomeprazole Fig5)

A line graph showing the percent of patients symptom-free over 28 diary days comparing Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The vertical axis shows percent symptom-free patients, and the horizontal axis represents diary days. The graph includes three distinct lines for each group with fluctuating symptom-free rates over time.*

FDA Label Image

Esomeprazole-structure (Esomeprazole Structure)

Chemical structure of Esomeprazole Magnesium depicted, showing the molecular arrangement including the magnesium ion complexed with the esomeprazole molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.